Literature DB >> 21039548

Solubilisation of drugs within liposomal bilayers: alternatives to cholesterol as a membrane stabilising agent.

M Habib Ali1, Daniel J Kirby, Afzal R Mohammed, Yvonne Perrie.   

Abstract

OBJECTIVES: The aim of this work was to investigate the effect of cholesterol on the bilayer loading of drugs and their subsequent release and to investigate fatty alcohols as an alternative bilayer stabiliser to cholesterol.
METHODS: The loading and release rates of four low solubility drugs (diazepam, ibuprofen, midazolam and propofol) incorporated within the bilayer of multilamellar liposomes which contained a range of cholesterol (0-33 mol/mol%) or a fatty alcohol (tetradecanol, hexadecanol and octadecanol) were investigated. The molecular packing of these various systems was also investigated in Langmuir monolayer studies. KEY
FINDINGS: Loading and release of drugs within the liposome bilayer was shown to be influenced by their cholesterol content: increasing cholesterol content was shown to reduce drug incorporation and inclusion of cholesterol in the bilayer changed the release profile of propofol from zero-order, for phosphatidyl choline only liposomes, to a first-order model when 11 to 33 total molar % of cholesterol was present in the formulation. At higher bilayer concentrations substitution of cholesterol with tetradecanol was shown to have less of a detrimental impact on bilayer drug loading. However, the presence of cholesterol within the liposome bilayer was shown to reduce drug release compared with fatty alcohols. Monolayer studies undertaken showed that effective mean area per molecule for a 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC):cholesterol mixture deviated by 9% from the predicted area compared with 5% with a similar DSPC:tetradecanol mixture. This evidence, combined with cholesterol being a much more bulky structure, indicated that the condensing influence of tetradecanol was less compared with cholesterol, thus supporting the reduced impact of tetradecanol on drug loading and drug retention.
CONCLUSIONS: Liposomes can be effectively formulated using fatty alcohols as an alternative bilayer stabiliser to cholesterol. The general similarities in the characteristics of liposomes containing fatty alcohols or cholesterol suggest a common behavioural influence for both compounds within the bilayer.
© 2010 The Authors. Journal compilation © 2010 Royal Pharmaceutical Society of Great Britain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21039548     DOI: 10.1111/j.2042-7158.2010.01090.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  13 in total

Review 1.  Methodologies to assess drug permeation through the blood-brain barrier for pharmaceutical research.

Authors:  Céline Passeleu-Le Bourdonnec; Pierre-Alain Carrupt; Jean Michel Scherrmann; Sophie Martel
Journal:  Pharm Res       Date:  2013-06-26       Impact factor: 4.200

2.  Ultra-Low-Dose Ultrasound Molecular Imaging for the Detection of Angiogenesis in a Mouse Murine Tumor Model: How Little Can We See?

Authors:  Shiying Wang; Elizabeth B Herbst; F William Mauldin; Galina B Diakova; Alexander L Klibanov; John A Hossack
Journal:  Invest Radiol       Date:  2016-12       Impact factor: 6.016

3.  Preparation, characterisation and entrapment of a non-glycosidic threitol ceramide into liposomes for presentation to invariant natural killer T cells.

Authors:  Randip Kaur; Jili Chen; Amina Dawoodji; Vincenzo Cerundolo; Yoel R Garcia-Diaz; Justyna Wojno; Liam R Cox; Gurdyal S Besra; Behfar Moghaddam; Yvonne Perrie
Journal:  J Pharm Sci       Date:  2011-01-31       Impact factor: 3.534

4.  Engineering the lipid layer of lipid-PLGA hybrid nanoparticles for enhanced in vitro cellular uptake and improved stability.

Authors:  Yun Hu; Reece Hoerle; Marion Ehrich; Chenming Zhang
Journal:  Acta Biomater       Date:  2015-09-30       Impact factor: 8.947

5.  Left-shifted nav channels in injured bilayer: primary targets for neuroprotective nav antagonists?

Authors:  Catherine E Morris; Pierre-Alexandre Boucher; Béla Joós
Journal:  Front Pharmacol       Date:  2012-02-23       Impact factor: 5.810

6.  An Investigation into Some Effective Factors on Encapsulation Efficiency of Alpha-Tocopherol in MLVs and the Release Profile from the Corresponding Liposomal Gel.

Authors:  Hosseinali Tabandeh; Seyed Alireza Mortazavi
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

7.  Point of use production of liposomal solubilised products.

Authors:  Swapnil Khadke; Peter Stone; Aleksey Rozhin; Jerome Kroonen; Yvonne Perrie
Journal:  Int J Pharm       Date:  2017-12-08       Impact factor: 5.875

8.  pH-sensitive niosomes: Effects on cytotoxicity and on inflammation and pain in murine models.

Authors:  Federica Rinaldi; Elena Del Favero; Valeria Rondelli; Stefano Pieretti; Alessia Bogni; Jessica Ponti; François Rossi; Luisa Di Marzio; Donatella Paolino; Carlotta Marianecci; Maria Carafa
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

9.  Microfluidic manufacturing of different niosomes nanoparticles for curcumin encapsulation: Physical characteristics, encapsulation efficacy, and drug release.

Authors:  Mohammad A Obeid; Ibrahim Khadra; Abdullah Albaloushi; Margaret Mullin; Hanin Alyamani; Valerie A Ferro
Journal:  Beilstein J Nanotechnol       Date:  2019-09-05       Impact factor: 3.649

10.  Exploring the correlation between lipid packaging in lipoplexes and their transfection efficacy.

Authors:  Behfar Moghaddam; Sarah E McNeil; Qinguo Zheng; Afzal R Mohammed; Yvonne Perrie
Journal:  Pharmaceutics       Date:  2011-11-18       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.